Literature DB >> 26273935

Twelve Hours In Vitro Biocompatibility Testing of Membrane Oxygenators.

Christian Bleilevens1, Oliver Grottke, Sabine Tillmann, Markus Honickel, Rüedger Kopp, Jutta Arens, Rolf Rossaint.   

Abstract

In vitro test systems for extracorporeal membrane oxygenation (mock loop) represent an interesting alternative to complex and expensive in vivo test systems to analyze the pathomechanisms leading to insufficient biocompatibility. Data on mock loop systems are limited, and operation times are constricted to a maximum duration of 6 hr. This study aims at a 12 hr operation time and frequent monitoring of markers for insufficient biocompatibility in two experimental settings. Porcine blood circulated in a mock loop without any modifications, or the circuit was operated with a CO2-enhanced gas (5% CO2/21% O2/74% N2) in combination with a nutrient solution (phosphate-adenine-glucose-guanosine-saline-mannitol). Coagulation parameters changed over time without differences between the two groups. In the unmodified test setting, a pH increase was detected after 1 hr, followed by significantly increased levels of free hemoglobin as a marker for hemolysis and elevated numbers of activated platelets, which correlate with detected von Willebrand factor, microparticles, and interleukin-β. Proinflammatory cytokine levels were significantly increased after 12 hr. In contrast, these parameters remained constant in the modified test setting providing proof of a stable operating in vitro mock loop system with an extended/prolonged operation time.

Entities:  

Mesh:

Year:  2015        PMID: 26273935     DOI: 10.1097/MAT.0000000000000252

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  5 in total

Review 1.  In Vitro models for thrombogenicity testing of blood-recirculating medical devices.

Authors:  Deepika N Sarode; Shuvo Roy
Journal:  Expert Rev Med Devices       Date:  2019-06-10       Impact factor: 3.166

2.  A Novel Mock Circuit to Test Full-Flow Extracorporeal Membrane Oxygenation.

Authors:  Stefan Caspari; Leonie S Schwärzel; Anna M Jungmann; Nicole Schmoll; Frederik Seiler; Ralf M Muellenbach; Marcin Krawczyk; Quoc Thai Dinh; Robert Bals; Philipp M Lepper; Albert J Omlor
Journal:  Membranes (Basel)       Date:  2022-04-30

3.  Towards Biohybrid Lung Development: Establishment of a Porcine In Vitro Model.

Authors:  Simon Schlör; Michael Pflaum; Klaus Höffler; Christian Kühn; Axel Haverich; Bettina Wiegmann
Journal:  Membranes (Basel)       Date:  2022-07-03

Review 4.  Toward a Long-Term Artificial Lung.

Authors:  Jutta Arens; Oliver Grottke; Axel Haverich; Lars S Maier; Thomas Schmitz-Rode; Ulrich Steinseifer; H P Wendel; Rolf Rossaint
Journal:  ASAIO J       Date:  2020-08       Impact factor: 3.826

5.  Platelet count reduction during in vitro membrane oxygenation affects platelet activation, neutrophil extracellular trap formation and clot stability, but does not prevent clotting.

Authors:  Patrick Winnersbach; Jan Rossaint; Eva M Buhl; Smriti Singh; Jonas Lölsberg; Matthias Wessling; Rolf Rossaint; Christian Bleilevens
Journal:  Perfusion       Date:  2021-01-21       Impact factor: 1.972

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.